Home › Trials › NCT04674969

Registry for real-world treatment of peripheral vascular lesions

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)

Boston Scientific Corporation · NCT04674969

This study is trying to see how well drug-eluting devices from Boston Scientific work for treating peripheral vascular diseases in a wide range of patients in real-world settings.

Quick facts

Study typeObservational
Enrollment5000 (estimated)
Ages18 Years and up
SexAll
SponsorBoston Scientific Corporation (industry)
Locations79 sites (Jonesboro, Arkansas and 78 other locations)
Trial IDNCT04674969 on ClinicalTrials.gov

What this trial studies

The ELEGANCE Registry aims to gather Real-World Data (RWD) on the treatment of peripheral vascular diseases using commercially available drug-eluting devices from Boston Scientific Corporation. This global, prospective, non-randomized, open-label registry will include diverse patient populations that have been underrepresented in previous clinical trials. The data collected will encompass health economics and safety information to support the effective use of these devices in clinical practice.

Who should consider this trial

Good fit: Ideal candidates for this registry are patients aged 18 years and older who require treatment for lesions in the peripheral vasculature using Boston Scientific drug-eluting devices.

Not a fit: Patients with a life expectancy of less than one year may not benefit from participation in this registry.

Why it matters

Potential benefit: If successful, this registry could enhance the understanding and treatment of peripheral vascular diseases, leading to improved patient outcomes.

How similar studies have performed: Other studies utilizing real-world data for similar conditions have shown promise, indicating that this approach could yield valuable insights.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Patients 18 years and older
* Written informed consent (patient data release-form)
* Use of any commercially available Boston Scientific drug-eluting device marketed for treatment of lesions in the peripheral vasculature and specified in the Registry Enrollment Guide

Exclusion Criteria:

* Life expectancy of \<1 year

Where this trial is running

Jonesboro, Arkansas and 78 other locations

+29 more sites — see ClinicalTrials.gov for the full list.

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Peripheral Vascular Diseases

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.